The protective power is 79.34%. How is the inactivated vaccine in COVID-19 immunized?

2020 is really a very difficult year. A sudden epidemic forced people all over the country to stay at home and isolate themselves 14 days. All walks of life have been greatly impacted. Fortunately, great achievements have been made in the national anti-epidemic in China. Even COVID-19 vaccine has been successfully developed and put into use. As of June 65438+1October 16544. More than 654.38 million people were vaccinated with COVID-19 vaccine. According to clinical experimental data, the protective power is 79.34% and the seroconversion rate is 99.52%.

How is the vaccine immunized?

Many people have common sense. Vaccine kills the virus activity by various technical means, and reserves part of the gene sequence of the virus and injects it into human body, so that the immune ability of human body reacts with the inactivated virus, thus making human body have the ability to resist this virus. Inactivated COVID-19 vaccine is to kill a part of the virus isolated from the new coronavirus and inject it into human body through technology. Inactivating virus disease has no ability to cure the disease, but it can stimulate human immune response. The so-called neutralizing antibody refers to the antibody that can fight pathogens and is the basis of whether the vaccine can protect the human body. The neutralization anti-seroconversion rate of 99.52% means that most people who have been vaccinated have produced antibodies.

COVID-19's vaccine was a resounding success.

The protective efficiency of COVID-19 vaccine is 79.34%, that is to say, 80 out of every 65,438+000 people vaccinated successfully produce antibodies, and they are protected by vaccination. From then on, you don't have to worry about COVID-19's influence. The vaccine standard put forward by the World Health Organization is that the protection efficiency should not be lower than 50%, which is much higher than the WHO standard. The higher the efficiency of vaccine protection, the higher the efficiency of group immunization, and China wins.

National pride behind COVID-19 vaccine

The successful vaccination of inactivated vaccine in COVID-19 is inseparable from the efforts of researchers. Under normal circumstances, it takes a long time for a vaccine to go through research and development and human trials from research and development to successful marketing. However, in special period and special treatment, COVID-19 vaccine is urgently needed. In such a hasty situation, China was able to successfully complete this task, providing the masses with another unbreakable line of defense, which is the China speed. At this moment, a deep sense of national pride arises spontaneously.